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ABSTRACT  
Defects in the mRNA export scaffold protein GANP, encoded by the MCM3AP gene, cause 
autosomal recessive early-onset peripheral neuropathy with or without intellectual disability. We 
extend here the phenotypic range associated with MCM3AP variants, by describing a severely 
hypotonic child and a sibling pair with a progressive encephalopathic syndrome. In addition, our 
analysis of skin fibroblasts from affected individuals from seven unrelated families indicates that 
disease variants result in depletion of GANP except when they alter critical residues in the Sac3 
mRNA binding domain. GANP depletion was associated with more severe phenotypes compared 
with the Sac3 variants. Patient fibroblasts showed transcriptome alterations that suggested intron 
content dependent regulation of gene expression. For example all differentially expressed intronless 
genes were downregulated, including ATXN7L3B, which couples mRNA export to transcription 
activation by association with the TREX-2 and SAGA complexes. Our results provide insight into 
the molecular basis behind genotype-phenotype correlations in MCM3AP-associated disease, and 
suggest mechanisms by which GANP defects might alter RNA metabolism.   
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INTRODUCTION 
We and others have recently established that biallelic variants in minichromosome maintenance 
complex component 3 associated protein (MCM3AP) cause peripheral neuropathy with or without 
impaired intellectual development (PNRIID, MIM 618124) (1,2,3,4). This childhood-onset 
neurologic syndrome is progressive and causes distal motor impairment and gait difficulties, often 
resulting in wheelchair dependency, and in difficulties using proximal limbs. Most affected 
individuals have impaired intellectual development or learning difficulties, although some have 
normal cognition. Electrophysiological testing and sural nerve biopsy are most compatible with an 
axonal sensorimotor neuropathy, whereas some patients have signs of demyelination. Additional 
features may include upper motor neuron signs, cerebellar ataxia, eye movement abnormalities, 
characteristic claw hands and foot deformities, and scoliosis. Moreover, the phenotypic range of 
MCM3AP-associated disease was expanded by a report of patients who developed peripheral 
neuropathy and multiple sclerosis type disease (5) and segregation of a heterozygous variant in a 
family with periodic paralysis (6).  
MCM3AP encodes for germinal center associated nuclear protein (GANP), which is a 218 kDa 
ubiquitously expressed protein (7,8). GANP forms a scaffold for several interacting proteins in the 
Transcription Export-2 (TREX-2) complex that facilitates the nuclear export of a subset of mRNAs 
through nuclear pore complexes (NPCs) (7,8,9,10). NPCs on the nuclear envelope are composed of 
nucleoporins, which form channels that have phenylalanine-glycine (FG) repeats in the middle, 
forming a mesh-like network that mediates selective exchange of components between the nucleus 
and cytoplasm. GANP is a multi-domain protein in which the N-terminus contains a cluster of six 
nucleoporin-like FG repeats. In the middle, GANP has a Sac3 (Suppressor of actin 3) mRNA 
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binding domain that shows a high homology from yeast to metazoans (11,12,13). In yeast, Sac3 
interacts physically with nucleoporins to mediate recruitment of the mRNA export machinery to the 
NPCs (11,12,14). At its C-terminus, GANP has an acetyltransferase domain that is crucial for 
localization to the nuclear envelope and has been described as involved in acetylation of MCM3 
during DNA replication (15,16). 
The export of mRNAs is tightly coupled to their transcription and processing, with strict quality 
control preventing the export of misprocessed messengers, in particular pre-mRNAs with unspliced 
introns (17). Thus, a defect in a particular step from transcription, mRNA maturation and 
termination to export, is likely to have direct consequences on both upstream and downstream steps. 
In human cells, two large transcription export complexes TREX and TREX-2 link transcription to 
mRNA export. They recognize mRNAs during early stages of biogenesis and transfer the mature, 
spliced mRNAs to the NXF1:NXT1 nuclear export factor, which facilitates their export to the 
cytoplasm through interactions with the FG repeats of nucleoporins. TREX is recruited to mRNAs 
during splicing (18). TREX-2 is based on a GANP scaffold to which PCID2, DSSI, ENY2 and 
CETN2/3 bind (10). TREX-2 is also associated with transcription through the interaction of ENY2 
and GANP with RNA polymerase II (10). The multiprotein complexes involved in transcription, 
processing and export share protein components and modules reciprocally, allowing coordination or 
modulation of these processes (19). For example, ENY2 in the TREX-2 complex is also utilized by 
the histone deubiquitinase (UBA) module of the large transcriptional co-activator SAGA (Spt-Ada-
Gcn5 acetyltransferase) complex (20,21). In Drosophila melanogaster, TREX-2 and SAGA are 
proposed to co-regulate transcription and mRNA export (22).  
Subsets of mRNAs can be exported selectively, but the molecular machinery involved and their 
regulation are unclear. In a fly study, NXF1 was found to export most but not all mRNAs (23). On 
the contrary, a deficiency in THOC5, a component of the TREX complex, decreased the 
cytoplasmic expression of only a small subset of mRNA enriched for those required for 
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hematopoietic development (24) whereas TREX-2, through GANP, promoted the nuclear export of 
specific mRNA classes required for gene expression itself, such as RNA processing, splicing, 
mRNP and ribosome biogenesis (25). Furthermore, transcripts selectively regulated by GANP in 
colon cancer cells had fewer introns than those regulated by GANP and NXF1 together or NXF1 
only, suggesting that GANP may facilitate rapid changes in gene expression by regulating the 
export of genes that require less processing (9).  
We have previously suggested a genotype-phenotype correlation for pathogenic variants in 
MCM3AP whereby patients with missense variants in Sac3 domain present with milder motor 
phenotypes compared to patients who have compound heterozygous variants affecting other parts of 
the protein (26). To investigate the molecular consequences of the different mutation types on 
GANP localization and function, we have studied here skin fibroblasts from multiple patients with 
MCM3AP-associated disease. We found that more severe phenotypes were characterized by near 
complete loss of GANP at the nuclear envelope, whereas missense variants in the Sac3 domain of 
GANP did not lead to GANP depletion. Furthermore, GANP defects impacted the overall mRNA 
expression in patient fibroblasts, with differentially expressed genes showing intron content 
dependency. Overall the present study suggests that GANP deficiency impairs transcription and/or 
export of specific mRNAs, which provides novel insight into the roles of GANP in human disease.  
 
RESULTS 
Novel MCM3AP variants and the associated phenotypes 
We identified two new families, one in the Netherlands and one in Estonia, with variants in 
MCM3AP, by genome or exome sequencing. Clinical features of these and previously reported 
patients with autosomal recessive disease are listed in Supplementary material Table S1. 
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddaa051/5810984 by guest on 01 April 2020
8 
 
The affected individual in Dutch family (NL2) is a girl with severe hypotonia and intellectual 
disability. The patient is a now 4 years 9 months old, born as the first child of healthy, non-
consanguineous parents (father Dutch, mother Thai). From the age of 3 months there were concerns 
about motor development, as she had poor head control. She was referred to a paediatric neurologist 
at age 7 months. Neurologic examination showed no signs of motor and sensory neuropathy, and 
her neurological features rather suggested a central defect. At age 16 months she was referred to a 
clinical geneticist because of motor delay, hypotonia, swallowing problems, and abnormal 
(dyskinetic) movements. She was not dysmorphic. 
At the age of 2 years 2 months she had slow motor progression and spoke some words. Her best 
motor milestone was rolling at the age of 2 years. Attempts to crawl were hampered by a cast for 
severe scoliosis that she had developed. At the age of 3 years 5 months she spoke only 6 words. At 
the age of 4 years 8 months – after a period of viral infections – she started to regress. She could no 
longer move her legs against gravity. She became short of breath when lying on her back. She had 
recurrent upper airway infections and progressive severe scoliosis. At age 4 years she required 
placement of a gastrostomy tube because of poor weight gain and vomiting.  During a period of 
high fever her respiratory capacity dropped and she was placed on ventilatory support, which is still 
required at age 4 years 9 months. 
A brain MRI at the age of 10 months was normal. At age 4 years 9 months hyper intensity of the 
basal ganglia, and mild ventriculomegaly, were seen. The radiologic finding was suggestive of a 
metabolic abnormality. 
An EMG at the age of 4 years 9 months showed affected motor and sensory fibers, with severe 
polyneuropathy. 
Array analysis showed three copy number variants, paternal duplication of 4p and deletion of 5q, 
and maternal deletion of 7q. Whole exome analysis identified a maternally inherited intronic variant 
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c.4290+3G>T in MCM3AP, predicted to affect the splicing of exon 20, and a paternally inherited 
frameshift variant c.3476_3477del (p.Gln1159Argfs*8), predicted to lead to a premature 
termination (Figure 1A). Neither variant is found in the ExAC variant database.  
The Estonian family (EST) has two affected siblings. Both are in their late twenties (brother, EST1; 
sister, EST2). They were born at full term to non-consanguineous Estonian parents following an 
unremarkable pregnancy. Their birth weights were relatively small (-1.75SD) but the length was 
0SD and the head circumferences were not known. Mild psychomotor developmental delay was 
noticed in the first year of life (head control at age 5 months; standing independently at the age of 
12 months). Both siblings had severe generalized epilepsy and mild spastic diplegia, diagnosed at 
the age of 3.5 years (EST1) and 8 years (EST2). They both began to learn at a conventional school 
with a conventional learning program. However, already at the age of 11 years (EST2) and 12 years 
(EST1) progressive encephalopathy was diagnosed in addition to polyneuropathy, and soon drug 
resistant epilepsy presented. The EEG showed slow background activity accompanied by frequent 
epileptiform activity. At this age, the head circumference, weight and length were normal. Over the 
years, the symptoms constantly progressed: most of the learned skills disappeared; both patients 
developed muscle atrophy, spasticity and joint contraction; ataxia and dysarthria; aggression and 
behavioral problems (mostly EST1). At the age of 26-27 years, both individuals are mostly 
bedridden. They can sit but not stand or walk. They have moderate to severe intellectual disability 
and drug-resistant epilepsy (1-10 seizures per day).  
The EST siblings have the heterozygous c.3814G>A (p.Val1272Met) missense variant, which we 
previously reported in a Finnish family (2), and a maternally inherited novel frameshift variant 
c.5423delG (p.Gly1808Aspfs*5) (Figure 1A). Comparison of the sequencing data of the previously 
reported Finnish patients and the Estonian patients suggested that affected individuals from these 
families have the same haplotype on the c.3814G>A (p.Val1272Met) allele as each patient also 
shared two rare intronic variants in the gene (hg19: 21-47662706T>C and 21-47690191G>A). 
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These variants as well as the disease variant (21-47676821C>T) are enriched in the Finnish 
population, each having an allele frequency of about 0.0025 according to gnomAD database. 
We previously found a decrease in mRNA levels of MCM3AP in patient fibroblasts (2). We now 
assessed MCM3AP mRNA levels in the skin fibroblasts of the NL2, EST1 and EST2 patients by 
quantitative PCR (qPCR), normalized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
All three patients had approximately 30% of MCM3AP mRNA remaining in comparison to the 
expression level in healthy control fibroblasts (Figure 1B). As all patients carried frameshift 
variants on one allele, which are expected to result in mRNA degradation, the qPCR result 
suggested that the second variant in each case also affected mRNA stability.  
 
GANP missense variants in Sac3 domain are clustered and probably impair interaction with 
RNA 
Disease associated MCM3AP variants can be roughly divided into two classes: missense variants in 
the Sac3 domain of GANP and compound heterozygous variants outside Sac3 (Supplementary 
material, Table S1). Homozygous missense variants in Sac3 have been described in several patients: 
p.Met762Thr in a Turkish family (2); p.Ser951Pro in an Iranian family (4) (IR cell line in this 
study); p.Arg878His in a Kurdish family (4), p.Glu915Lys in a Dutch family (1), and p.Leu870Ser 
in a Lebanese family (3). In addition, the Sac3 variant p.Ala867Asp has been found in combination 
with a nonsense variant p.Tyr899* in an Australian family (AUS cell line in this study) (2) (Figure 
1C). Furthermore, peripheral neuropathy and multiple sclerosis was associated with homozygous 
p.Ile954Thr variant (5). Amino acid conservation of the recessive Sac3 missense variants is shown 
in Supplementary material, Figure S3. To investigate in silico the location of these missense 
variants in structure of the Sac3 domain, we exploited the high level of conservation between the 
human GANP:PCID2:DCCI complex and the S. cerevisiae Sac3:Thp1:Sem1 complex for which a 
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crystal structure is available (27,28). The structure of both PCID2/Thp1 and GANP/Sac3 in this 
region have a PCI fold (29) based on a series of helical tetratricopeptide repeats (TPR) capped by a 
winged helix domain (Figure 1D, Supplementary material, Movie S1). All but one of the Sac3 
domain variants observed in the GANP patients are clustered in a region that lies in the winged 
helix domain close to its junction with the TPR region, whereas the remaining variant is in the TPR 
region immediately adjacent to the winged helix domain. Moreover, these variants are primarily in 
the interior of the protein and so probably generate local changes in structure. This winged helix 
region of Sac3, together with the adjacent PCID2, are associated with binding to RNA (28) and so 
local structural changes introduced by these variants would be expected to impair RNA binding 
either directly or indirectly by impairing the binding of PCID2. 
 
Compound heterozygous MCM3AP variants outside Sac3 domain lead to decreased GANP in 
nuclear envelope  
To assess the consequences of MCM3AP variants on GANP protein, we studied skin fibroblasts 
from nine affected individuals from families FIN, AUS, USA, NL1, NL2, EST, IR and the 
unaffected mothers of NL1 (NLM) and IR (IRM) (Figure 1C, Table 1). All other patients carried 
compound heterozygous variants outside Sac3 domain, except the AUS patient, who had a 
heterozygous Sac3 missense variant together with a nonsense variant, and the IR patient, who 
carried the homozygous S951P variant in Sac3 domain (Figure 1C). We used a polyclonal antibody 
that recognizes the N-terminal region of GANP to perform immunostaining on these fibroblasts 
(Figures 2A-C). Staining was done on three different occasions, upon receipt of the different patient 
cell lines (Figures 2A-C). In summary, cells from affected individuals from families FIN, NL1, 
USA, EST and NL2 showed greatly reduced GANP staining at both the nuclear envelope and the 
nuclear interior when compared to control fibroblast lines (Figure 2A-B). In contrast to all other 
patient lines, the AUS and IR cell lines carrying Sac3 missense variants had a GANP staining 
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comparable to that of the controls (Figure 2A, C). We quantified the GANP signal by manually 
counting the stained cells and grouping them depending on the intensity of staining at the nuclear 
envelope. GANP+ denoted a clear presence of GANP, GANP- denoted absence of GANP, and 
intermediate cells had faint GANP staining at the nuclear envelope (Figure 2D). The quantification 
showed the highest number of GANP+ cells in controls (from 61% to 100%) and AUS (91%), as 
well as IR/IRM (from 95% to 100%) consistent with the visual observation (Figure 2E). Unaffected 
heterozygous carrier NLM had mostly GANP+ cells (64%). Fibroblast lines of FIN, NL1, NL2, and 
EST had about 1% of GANP+ cells whereas USA fibroblasts had none (0%). The ratio of GANP 
staining in counted cells was significantly different in all patients with variants outside the Sac3 
domain (FIN1/2, EST1/2, NL1, NL2, USA) in comparison to controls (p<0.001 for each patient), 
whereas patients with Sac3 variants did not differ from controls. Staining results of controls in the 
last two experiments are shown in Supplementary material, Figure S1. Western blot analysis of 
GANP, which was performed in some fibroblast lines, was consistent with the immunostaining 
results (Supplementary material, Figure S2).  
In conclusion, these results showed that compound heterozygous MCM3AP variants outside the 
Sac3 domain resulted in a decreased GANP level at the nuclear envelope. In contrast, patients with 
Sac3 domain variants had normal GANP expression and localization. 
 
Nuclear envelope ultrastructure in absence of GANP is normal 
We used three fibroblast lines from affected (FIN1, FIN2, AUS) and two from healthy individuals 
for ultrastructural assessment by transmission electron microscopy (TEM) (Figure 3). The 
appearance of the nuclear envelope, nuclear pores, and nucleoli and the general appearance of cells 
were normal in the GANP-depleted fibroblasts (FIN1/2) and in AUS cells carrying the Sac3 
missense variant.  
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Affected individuals share a transcriptome signature in fibroblasts  
Next, we assessed whether disease associated GANP defects influenced gene expression in 
fibroblasts. mRNA from fibroblast lines FIN1/2, AUS, USA, NL1, NLM and two unrelated controls 
(one male, one female) were deep sequenced using paired-end sequencing using two technical 
replicates. We compared the overall gene expression profiles by hierarchical correlation analysis 
(Figure 4A). To test if any gene expression alteration correlated with GANP deficiency, we 
performed differential gene expression (DE) analysis using DESeq2 (30) comparing patients to 
healthy controls. This analysis identified 51 downregulated and 110 upregulated genes (compared 
to control fibroblasts, FDR<0.01) (Figure 4B). MCM3AP mRNA levels were significantly reduced 
(log2FC = -0.81, FDR = 1.32
-06
), as expected based on qPCR results.  
To identify potential pathways affected by GANP deficiency, we used REACTOME, KEGG, DO 
and GO enrichment analysis (Figure 4D). Although this study was done using patient fibroblasts, 
which are not the affected cell type in these patients, DO gene sets identified pathways related to 
brain developmental disorders and epilepsy, and REACTOME identified pathways related to 
neuronal processes. In particular, altered genes were related to neuronal adhesion (NRXN3), protein-
protein interactions at synapses (SLITRK1, NLGN1, APBA2), potassium channels (KCNA7, 
KCNMA1, KCNQ5) and other neuronal and synaptic processes (RIMS1, GRIA1, GABRB3, PTPRD, 
CACNB4) (Figure 4C). 
GANP has been previously suggested to be selectively involved in the export of highly expressed 
and rapidly regulated genes, which tend to be shorter and have fewer introns than genes in general 
(9). Therefore, we examined the number of introns in the identified DE genes. Interestingly, we 
noticed that the distribution of exons was significantly different between up- and downregulated 
genes (Figure 5A), by Wilcoxon rank sum test with continuity correction (Mann-Whitney U test W 
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= 1772.5, p-value<0.0002). For example, of the 51 downregulated DE genes, 15 were intronless, 
whereas all upregulated genes had introns (Figure 5B). We validated the downregulation of three 
intronless genes ATXN7L3B (p<0.0001), TSPYL4 (p<0.0001) and EID1 (<0.0001) by qPCR, 
including eight patient lines in the analysis in comparison to control cells (Figure 5C). 
Taken together, these results suggest that GANP defects in patient fibroblasts affect the expression 
of a limited number of genes, and that intron content is a contributing factor. 
 
ATXN7L3B mRNA expression but not localization is altered in patient cells 
ATXN7L3B protein, encoded by one of the downregulated intronless genes (ATXN7L3B), interacts 
with ENY2 that functions as an adaptor protein in both the SAGA and TREX-2 complexes (31). 
Our qPCR analysis showed that ATXN7L3B mRNA levels were reduced by 39% on average in 
patient fibroblasts (Figure 5C). Interestingly, in line with this result, we noticed that the GEO 
(GSE54481) dataset of GANP siRNA knockdown in human HCT116 cells also indicated 
downregulation of ATXN7L3B (p=1.69e-09, adj.p.val=8.43e-06, logFC= -0.935) (9).   
To further study whether the ATXN7L3B mRNA localization was altered in patient cells, we used 
RNA in situ hybridization in fibroblasts from nine available patients and three controls with an 
ATXN7L3B specific probe. RNA quality of the samples was validated by using a probe targeting 
cyclophilin B (PPIB), and background staining was assessed by a probe targeting bacterial gene 
dapB. All samples expressed a high level of the PPIB and no signal was detected for dapB. In 
control cells, ATXN7L3B probe showed a strong punctate signal across the proximal and distal 
regions of the cytoplasm, whereas in patient cells the cytoplasmic signal was reduced (Figure 6A). 
Quantitation showed that the average number of puncta per cell was significantly lower in patient 
cell lines compared to control cell lines (p<0.05) (Figure 6B). No signs of ATXN7L3B mRNA 
retention in the nucleus was noted in patient or control cells. 
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Although other SAGA or TREX-2 subunits were unaltered in RNASeq analysis, we additionally 
validated the expression levels of ENY2, USP22 and ATXN7L3 using qPCR on the full set of patient 
lines. In agreement with the RNASeq results, ENY2 and USP22 were not altered, however, 
ATXN7L3 expression was increased by 27% on average in patient cells in comparison to controls 
(p=0.02) (Supplementary material, Figure S4).  
 
 
 
DISCUSSION 
Disruptions in RNA metabolism are increasingly recognized as causes of a range of neurological 
phenotypes (32). Owing to the complexity of mRNA life cycle and the interdependence of its 
different steps, it is not surprising that even small changes in the amount or activity of the 
machinery responsible may have wide-spread deleterious effects in neurons. Here we studied a 
protein recently associated to human neurological disease, GANP, which contributes to mRNA 
maintenance pathways, and to symptoms of peripheral and central nervous system disease.  
Several separate studies have now identified biallelic MCM3AP mutations as causes of neuropathy 
with or without intellectual disability (1,2,3,4,5). The phenotype of the EST patients in this study 
was similar to that of the previously described Finnish patients who carried the same p.Val1272Met 
variant combined with a different truncating variant. All patients from these two families had early 
disease onset with upper motor neuron signs, and lost ambulation in adolescence or early adulthood. 
The Estonian patients had additionally progressive encephalopathy starting around ages 11-12 
years. The patient NL2 had a severe motor phenotype with early central involvement. These 
findings increasingly indicate a role for GANP in central nervous system in addition to the 
peripheral nerves.  
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Because it forms the scaffold of the TREX-2 complex, GANP has a crucial role in mediating the 
export of mRNAs from nucleus to cytosol, and most likely also influences the upstream steps of 
mRNA transcription and processing (7,9). However, GANP function and regulation in human cells 
is not fully understood. Our molecular characterization of patient fibroblasts with various GANP 
defects showed that compound heterozygous MCM3AP variants outside the mRNA binding Sac3 
domain led to a dramatic decrease of the GANP protein at the nuclear envelope. In cells from these 
individuals GANP was nearly undetectable by immunostaining, whereas fibroblasts from Sac3 
variant carriers had normal GANP levels. Modeling of Sac3 disease variants in the S.cerevisae 
Sac3:Thp1:Sem1 complex suggested that the Sac3 variants associated with human disease may 
generate local structural changes that could in turn impair binding to RNA and so could provide a 
pathogenic mechanism in these cases when the levels of GANP protein remained near normal. 
Overall our studies indicate that MCM3AP-associated mutations cause loss of GANP function. The 
unexpectedly strong depletion of GANP in the compound heterozygous patients explains why the 
associated phenotypes are more severe than those caused by Sac3 variants. Nevertheless, the 
phenotypes caused by both mutation types are quite similar, suggesting that the loss of mRNA 
binding function of GANP is a principal mechanism by which neuronal function is impaired.  
Although skin fibroblasts are not the cell type affected in the MCM3AP-associated disease, 
detecting the severe GANP loss in the patient cells prompted us to study whether depletion of 
GANP has general effects on mRNA metabolism in fibroblasts. The neuronal disease could result 
from a molecular defect that is present in all cell types, but which only manifests in selected 
neurons due to profound downstream consequences of selected transcripts that are highly important 
in those neuron types. In line with GANP depletion having an effect, we found that fibroblasts from 
multiple affected individuals with different pathogenic variants shared similar transcriptional 
fingerprints. Higher proportion of differentially expressed genes were upregulated than 
downregulated, suggesting compensatory effects upon GANP depletion. Unexpectedly, many of the 
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upregulated genes were involved in neuronal functions. This could suggest that GANP has a 
specific role in the expression of neuronal transcripts that result in their misregulation even in a 
non-neuronal cell type. Future studies using GANP-deficient human neurons derived from induced 
pluripotent stem cells are required to investigate the involvement of these neuronal transcripts 
further. Of note, potassium channels within the differentially expressed genes may be of interest, as 
hypokalemic periodic paralysis was associated with a heterozygous missense Sac3 variant in one 
family (6).  
GANP has previously been found to have a role in selective mRNA export, affecting the transport 
of mRNAs differentially, with preference on genes that require less processing i.e. have less introns 
(9). We studied here the global effect of disease-associated GANP variants on steady-state mRNA 
levels, and not the effect on transport itself. We found no overall indication of GANP defects 
having a stronger effect on transcripts with fewer introns, but interestingly the distribution of intron 
content was different between significantly altered upregulated and downregulated genes, with 
downregulated genes having fewer introns. These findings suggest that GANP may have a role in 
the regulation of transcription and splicing processes in human cells in addition to mRNA export. In 
particular, we observed that many of the downregulated genes were intronless, whereas all 
upregulated genes had introns. Whereas it is known that intron-containing genes are surveyed by 
quality control mechanisms to ensure that unspliced mRNAs are not exported (17), the export 
mechanisms of intronless genes have not been investigated in great detail. TREX has been 
suggested to be involved in export of intronless mRNAs in HeLa cells (33), NXF1/TAP pathway in 
exporting intronless histone H2A mRNA (34) and nuclear pore basket protein TPR in export of 
intronless transcripts (35). ATXN7L3B was one of the downregulated intronless genes in patients’ 
cells where RNA in situ hybridization showed a reduction in its overall amount but no change in 
mRNA localization and no evidence for nuclear retention. Therefore, there appears to be a clear 
feedback from defect in GANP to steady-state mRNA levels depending on whether the genes have 
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introns to process. We speculate that in neurons, this effect on intronless genes may be rate-limiting 
for a set of key genes in development and maintenance of the nervous system. Furthermore, our 
results suggest that export of intronless mRNAs may require TREX-2 in addition to TREX. 
In the RNASeq analysis of GANP-deficient patient fibroblasts, ATXN7L3B was the only altered 
transcript of the TREX-2, TREX or SAGA complex subunits. ATXN7L3B binds ENY2 (36), which 
is a key protein in both the TREX-2 and SAGA complexes (10,31,36,37). SAGA is a large 
chromatin modifying coactivator complex with modules for the acetylation (HAT) and 
deubiquitination (DUB) of histones as well as non-histone substrates. The DUB module removes 
monoubiquitin from K120 of human H2B (H2Bub1) in genes, and has USP22 as the catalytic 
subunit, and ATXN7L3 and ENY2 as adaptor proteins for activity and stability. A recent study 
found that ATXN7L3B, a cytoplasmic paralog of ATXN7L3, expressed from a pseudogene, 
competes with it for ENY2 binding, thus inhibiting the ability of SAGA complex to deubiquitinate 
histones (36). Whereas we found decreased ATXN7L3B expression in patient cells, qPCR analysis 
indicated increased ATXN7L3, supporting a connection between these two factors. Recent study has 
interestingly linked the GANP and SAGA connection to genome stability, by showing that a 
functional interaction between human TREX-2 and the DUB activity of SAGA is needed to 
maintain the H2B/HB2Bub1 balance for efficient DNA repair and homologous recombination (38). 
These authors showed that, whereas cells lacking ENY2 had increased H2Bub1 levels due to 
decreased deubiquitination, GANP-depletion decreased global H2Bub1. Whether the human disease 
associated GANP defects have an effect on SAGA function requires further studies. Interestingly, 
ATXN7L3B may well have relevance for the neurological phenotypes associated with GANP 
defects, as two studies have described aberrations affecting the chromosomal region for ATXN7L3B 
with links to neurological phenotypes (39,40). In conclusion, our results suggest that GANP is a 
regulator of ATXN7L3B expression. 
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In summary, we describe central nervous system involvement in new affected individuals with 
MCM3AP variants, and provide a molecular explanation for the genotype/phenotype correlation 
through investigation of multiple cell lines from patients with GANP defects. Our results suggest a 
novel link between mRNA export and intron dependent regulation of gene expression in human 
disease. 
MATERIALS AND METHODS 
Fibroblast cell culture 
Human fibroblast cultures were established from skin punch biopsies and cultured by standard 
methods. Briefly, cells were cultured in 37°C in 5% CO2 and 95% O2 in DMEM media (#BE12-
614F, Lonza), 10% FBS, 1% Penicillin-streptomycin, 1% L-glutamate and 0.1% uridine. Low-
passage fibroblasts of affected individuals NL1 (female), USA (female), FIN1 (female), FIN2 
(male), AUS (female), NL2 (female), EST1 (male) and EST2 (female), IR (female), and NLM 
referring to mother of NL1 and IRM to mother of IR and two to four healthy volunteer controls 
were used for the experiments (controls are named per experiment). The affected individuals or 
their guardians gave a voluntary informed consent to participate in the experiments.  
Exome and genome sequencing 
For EST family whole genome sequencing and data processing were performed by the Genomics 
Platform at the Broad Institute of MIT and Harvard.  PCR-free preparation of sample DNA (350 ng 
input at >2 ng/ul) is accomplished using Illumina HiSeq X Ten v2 chemistry. Libraries are 
sequenced to a mean target coverage of >30x.  Genome sequencing data was processed through a 
pipeline based on Picard, using base quality score recalibration and local realignment at known 
indels. The BWA aligner was used for mapping reads to the human genome build 38. Single 
Nucleotide Variants (SNVs) and insertions/deletions (indels) are jointly called across all samples 
using Genome Analysis Toolkit (GATK) HaplotypeCaller package version 3.4. Default filters were 
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applied to SNV and indel calls using the GATK Variant Quality Score Recalibration (VQSR) 
approach. Annotation was performed using Variant Effect Predictor (VEP). Lastly, the variant call 
set was uploaded to seqr for collaborative analysis between the Broad Center of Mendelian 
Genomics and investigator.  
For NL2 family exome sequencing was outsourced to GenomeScan (Leiden, The Netherlands). In 
brief, exomes were captured using  the Agilent SureSelectXT Human all Exon v5 library kit 
(Agilent, Santa Clara, USA) accompanied by Illumina paired end sequencing on the Hiseq2500 
platform (Illumina, San Diego, USA), generating 2 × 150 bp paired end reads with at least 80x 
median coverage. Data analysis was performed at the LDGA using the in-house sequence analysis 
pipeline ‘Modular GATK-Based Variant Calling Pipeline’ (MAGPIE) (LUMC Sequencing 
Analysis Support Core, LUMC) based on read alignment using Burrows-Wheeler Alignment 
(BWA-MEM) and variant calling using the Genome Analysis Toolkit (GATK). LOVDplus (Leiden 
Genome Technology Center, LUMC, Leiden) was used for interpretation of variants. Variants were 
classified according to the American College of Medical Genetics and Genomics (ACMG) 
guidelines. 
Fibroblast RNA sequencing and bioinformatics analysis 
RNA was isolated from 90-100% confluent 10 cm plates, grown in culture for 4 days. Technical 
duplicates were sequenced and analyzed for all cell lines, which were passaged at the same time. 
All the fibroblast lines were in early passage stages and grew at approximately equal pace. Cells 
were washed with PBS once, scraped and centrifuged 1000 rcf for 5 min. Pellets were immediately 
processed for RNA isolation with Nucleospin RNA kit (#740955.50, Macherey-Nagel) according to 
manufacturer’s instructions including rDNAse treatment. RNA concentrations were measured with 
Agilent TapeStation and Nanodrop, RNA integrity was checked on a gel with Agilent TapeStation 
and RIN were > 9.6. RNA measurements and mRNA sequencing were done at Biomedicum 
Functional Genomics Unit with paired-end sequencing with Poly A binding beads and NEBNext 
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Ultra Directional RNA Library Prep and sequenced with Illumina NextSeq High Output 2 x 75bp. 
Target number of reads was 45-50M which was ensured by sequencing with Next Seq Mid Output 
flow cell.  
The raw data was demultiplexed with adapter removal using bcl2fastq2 (v2.20.0.422; Illumina). 
FASTQ-files were filtered with Trimmomatic (v.0.36; (41)) excluding non-paired, short (<35bp) 
and low quality (phread score <20) reads. The filtered reads were mapped to the human reference 
genome (GRCh38) with STAR (v. 2.5.3; (42)). Expression analysis was carried out in R (R 
Development Core Team & Core, 2018). Read counts for genes were extracted with Rsubreads 
(v.1.32.4; (43)) excluding duplicates, multimapping reads, chimeric fragments, and reads with low 
mapping quality (<10). Differential gene expression was analyzed using DESeq2 (v.1.22.2; (30)), 
comparing disease status (Control vs Patient). The technical replicates were combined, after 
confirming that the expression profiles were nearly identical. Genes with low reads depth (<50 
reads in total) were excluded from the analysis. The results from the expression analysis along with 
the raw sequence data was deposited to GEO, under accession GSE135098. 
cDNA synthesis and RT-PCR 
Fibroblast total RNA was isolated with Nucleospin RNA kit (#740955.50, Macherey-Nagel). cDNA 
was synthesized according to manufacturer’s instructions with Maxima First Strand cDNA 
Synthesis Kit (#K1671, Thermo Fisher Scientific).  
qRT-PCR 
Quantitative Real Time PCR for quantification of MCM3AP mRNA amount, as well as RNA 
sequencing validations was done with cDNA isolated as described above. qPCR was run on a 
CFX96 Touch Real-Time PCR detection system (Bio-Rad) with SYBR Green qPCR Kit (#F415S, 
Thermo Fisher Scientific) on a 96-well plate with gene-specific primers 10 µM and H20. The 
cycling protocol was 95°C for 7 min, then 40 cycles of 95°C for 10 s and 60°C for 30 s. The 
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primers were tested to fit on a standard curve. Normalization was done with GAPDH as a 
housekeeping gene. Technical triplicates were used for all studies. 12.5 ng of cDNA was used.  
Immunocytochemistry, Fluorescence microscopy and confocal microscopy  
Fibroblasts were grown in standard cell culture conditions as described above on cover glasses in 6 
or 24-well plates for four days, and media was changed every other day. The confluent cells were 
washed three times with PBS, fixed with 4% paraformaldehyde for 15 min and washed three times 
with PBS. Cells were then permeabilized in 0.2% Triton X-100 in PBS for 15 min in room 
temperature. Coverslips were washed three times in PBS-T (0.1% Tween-20) followed by blocking 
in 5% BSA/PBS-T (#001-000-162, Jackson Immuno Research) for two hours in room temperature 
on a shaker. Primary antibody in 5% BSA/PBS-T was incubated overnight in 4°C. The following 
day, coverslips were washed with PBS-T for 15 min three times, followed by incubation in 
secondary antibody in 5% BSA/PBST for one hour on a shaker. Finally, the cells were washed three 
times for 10 min and plated on glass with Vectashield (#H-1200, Vector Laboratories).  
Fibroblasts with GANP staining were quantified by manually counting under a fluorescent 
microscope (Zeiss). The number of GANP positive and negative cells were counted in a blinded 
manner from triplicate samples, from dapi positive nuclei, n
mean
=112 (first experiment) n
mean
=136 
(second experiment) n
mean
=90 duplicate samples (third experiment). The groups were GANP 
positive, GANP negative and moderately GANP positive nuclei. The fibroblasts were imaged with 
Zeiss LSM880 IndiMo Axio Observer laser scanning confocal microscope with ZEN black software 
with DyLight 594 (GANP) imaged with laser 561 and Dapi imaged with laser 405 using the same 
exposure time for all samples. Imaging objective was Plan-Apochromat 63x/1.4 Oil Dic M27 and 
images were acquired at 8-bit depth and 512x512 (experiments B and C) or 1380x1380 (experiment 
A) frame size. The settings for the 561 laser (excitation 561, emission 659) was: 1.4% laser power, 
binning 1x1. The results were visualized with Zen Blue, Image J and Graph Pad Prism Software. 
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RNA in situ hybridization 
RNA in situ hybridization was performed on fixed adherent fibroblast cells grown on 4-chamber 
slides using RNAscope Multiplex Fluorescent Reagent Kit Version 2 (#323100, Advanced Cell 
Diagnostics) for target detection according to instructions. Duplicates were analyzed for target 
probe and single wells for negative and positive controls per sample. In short, the cells were fixed in 
10% neutral buffered formalin and dehydrated in increasing concentrations of ethanol (50%, 70% 
and absolute ethanol). The cells were stored in absolute ethanol in -20°C until performing the RNA 
in situ hybridization. Next, the cells were rehydrated in decreasing concentrations of ethanol (70% 
and 50%) and washed in PBS. The probes PPIB (positive control, #313901), dapB (negative 
control, #310043), and ATXN7L3B (target probe, #804431) were hybridized for 2 h at 40°C 
followed by signal amplification and developing the HRP channel with TSA Plus fluorophore 
Cyanine 3 (1:1500 dilution) (NEL744001KT, Perkin Elmer) according to the manual. The cells 
were counterstained with DAPI and mounted with ProLong Gold Antifade Mountant (P36930, 
Invitrogen). The samples were scanned 3DHISTECH Pannoramic 250 FLASH II digital slide 
scanner using 40x objective and extended focus option with 7 focus levels. Punctae number were 
counted on Pannoramic viewer per cell and averaged per sample (average 24 cells per sample). 
Images were generated using 3DHISTECH Pannoramic 250 FLASH II digital slide scanner at 
Genome Biology Unit supported by HiLIFE. 
Western blotting 
Fibroblasts for protein analysis were grown on 10 cm petri dishes until confluent. The cells were 
isolated with 1X RIPA (#9806, Cell Signaling) for 5 min on ice, scraped and centrifuged at 14 000 
x g for 10 min at 4°C. Protein concentrations were measured with Bradford (#500-0006, Bio-Rad) 
from triplicate samples on x machine and with a standard curve. For SDS-PAGE analysis of 
affected and control fibroblasts, 30 µg of protein was loaded per well on a 10% TGX 10-well 
30µl/well gel (456-1033, Bio-Rad) for 1 hr. at 150V. Molecular size of bands was detected with 
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Protein Standard (#161-0374, Bio-Rad) and proteins loaded together with 4x Laemmli loading 
buffer (#161-0747, Bio-Rad) in 2-mercaptoethanol (#1610710, Bio-Rad). Gel was transferred into a 
nitrocellulose membrane (#1704158, Bio-Rad) and transferred using High Molecular Weight 
protocol in Trans-Blot Turbo (Bio-Rad). The blot was washed blocked in 5% milk/TBST for 1 hr in 
RT. For immunoblotting analysis, GANP antibody (1:1000) (#113295, Abcam) was incubated for 
48-72 hours in 4°C in 2,5% milk/BSA in TBS-T. The blot was washed three times for five min in 
TBS-T. Secondary antibody α-rabbit (1:5000) in 1% BSA/TBS-T was incubated for 1 hr at RT on a 
shaker and washed for three times a 10 min in TBS-T. The blot was visualized with ECL reaction 
with Pierce ECL Western Blotting Substrate (#32106, Thermo Fisher). Loading control GAPDH 
(#14C10) was incubated overnight in 4°C and processed otherwise in the same way. The images 
were obtained with a Chemidoc imager (Bio Rad) and quantified on Image Lab software (Bio-Rad). 
The quantification was done using GAPDH to normalize protein levels of GANP. Results were 
visualized on Graph Pad Prism Software. 
Antibodies 
α-rabbit N-terminal GANP antibody for immunocytochemistry was (#198173, Abcam), used at a 
ratio of 1:200. DyLight or Alexa 594 goat-anti-rabbit secondary (#35560, Thermo Fisher; Alexa 
fluor) was used to detect GANP at 1:1000. N-terminal antibody used for western blotting of α-
rabbit GANP (#113295, Abcam) was used at a ratio of 1:1000. Secondary antibody to detect GANP 
in immunoblotting was goat-anti-rabbit (#111-035-144, Jackson Immuno Research), at a ratio of 
1:5000.  
Molecular modeling 
The structure of GANP in the Sac3 region was based on the crystal structure of this region in the S. 
cerevisiae TREX-2 complex (27,28), PDB accession codes 3T5V and 5UBP. This modeling was 
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justified because of the high sequence homology between the human and yeast proteins in this 
region. Images and movies were generated using the CCP4MG software package.  
Transmission electron microscopy 
Fibroblast cultures on glass slides were fixed with 2% PFA + 2% Glutaraldehyde (Sigma) for 30 
min at 4°C, washed with PBS and finally with 2% Glutaraldehyde O/N at 4°C. Fixed cells were 
prepared according to standard protocols for transmission electron microscopy at the Electron 
microscopy Unit of the Institute of Biotechnology. Images were captured with the Jeol 1400 TEM 
microscope at 80,000V.  
Statistics  
Unpaired parametric two-tailed t-test was used for qRT-PCR and RNAScope experiments in which 
two biological groups were compared (affected individuals vs. controls). Significance was 
measured by p<0.05. Statistical tests were performed in Graph Pad Prism 7.04. Fisher’s exact test 
was used for analysis of immunocytochemical staining data. For intron distribution testing 
Wilcoxon rank sum test with continuity correction (Mann-Whitney U test) was used. For analysis of 
GEO siRNA data, analysis was run in GEO2R browser comparing GANP KD and control samples, 
and statistics were reported from the results table. All measured data points were included in the 
analysis.  
Data availability  
RNA-Seq data: Gene Expression Omnibus GSE135098 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE135098) 
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LEGENDS TO FIGURES 
TABLES  
Table 1. Human fibroblast lines used in this study.  
Affected 
individual 
designation 
(current 
study) 
Affected 
individual 
designation 
(original 
study) 
MCM3AP variants Reference  
FIN1 F:II-3 p.V1272M and p.P148fs* (2) 
FIN2 F:II-4 p.V1272M and p.P148fs* (2) 
AUS A:II-2 p.A867D and p.Y889* (2) 
NL1 N:II-1 p.Q619= and p.N1317fs18* (2) 
NLM N:I-2 heterozygous p.N1317fs18* (2) 
USA C-III.1 p.S1454_L1459dup and p.Q1804* (4) 
NL2 - p.S1478* and c.4290+3G> this study 
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EST1 - p.V1272M and p.G1808Dfs*5 this study 
EST2 - p.V1272M and p.G1808Dfs*5 this study 
IR - homozygous p.S951P (4) 
IRM - heterozygous p.S951P (4) 
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ABBREVIATIONS 
BSA Bovine serum albumin 
DE Differentially expressed 
EEG Electroencephalography 
EMG Electromyography 
ExAC The Exome Aggregation Consortium 
GEO Gene Expression Omnibus 
GO Gene Ontology 
MRI Magnetic resonance imaging 
NPC Nuclear pore complex 
PBS Phosphate buffered saline 
PFA Paraformaldehyde 
RCF Relative centrifugal force 
RIN RNA integrity number 
SDS-PAGE sodium dodecyl sulfate–polyacrylamide gel electrophoresis 
TBS Tris-buffered saline 
TEM Transmission electron microscopy 
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Figure 1. Novel variants in MCM3AP and structural modeling of Sac3 domain variants.  
A. Family pedigrees of EST and NL2. B. qPCR quantification of MCM3AP mRNA levels in EST1, 
EST2 and NL2 patient and four control fibroblasts normalized to GAPDH. The mean of three 
technical replicates is shown for each cell line as dots. Bars show mean of control or patient cells. 
Error bars indicate SD. ** p<0.0001. C. Map of GANP variants investigated in this study. Variants 
in new families are shown in black and previously reported variants in grey. D. Modelling of 
mutations in Sac3 domain. The secondary structure of the GANP, PCID2 and DCCI chains is 
shown using different colors to identify specific components. The winged-helix regions of GANP 
and PCID2 are shown as yellow and red, respectively, their TPR (tetratricopeptide repeats) regions 
in green and magenta, respectively, and DCCI as light blue.  All of the disease-associated missense 
variants (black) are located either in the GANP winged-helix domain (shown as yellow secondary 
structure) or in the GANP TPR region (shown as green) immediately adjacent to the winged helix 
domain.  The residues mutated are primarily located in the interior of the structure and so are likely 
to generate local perturbations in the molecular conformation in this region.  Although Ser951 is 
located on the surface, it lies within a helix and, because it is mutated to Pro, a residue that is 
incompatible with an α-helix, this mutation would also probably generate a local structural 
perturbation.  It is likely that the local structural perturbations introduced by these mutations could 
influence the binding of RNAs to the GANP:PCID2:DCCI complex, either directly by changing the 
conformation of the GANP winged helix domain, or indirectly by altering the interaction between 
GANP and PCID2.   
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Figure 2. Variants outside Sac3 domain cause loss of GANP protein. 
Immunocytochemistry with an N-terminal GANP antibody in patient fibroblasts. A. Confocal 
images of patient group A (AUS, FIN1, FIN2, USA, NL1) and control fibroblasts stained with 
GANP antibody show normal localization to the nuclear envelope and interior in control and AUS 
cells, and reduction in staining in other affected individuals’ cell lines. NLM refers to cell line of 
mother of NL1. B. Confocal images of patient group B (EST1, EST2, NL2). C. Confocal images of 
patient group C (IR). IRM refers to cell line of mother of IR. D. Example of categorization of cells 
into GANP +, GANP intermediate or GANP –. E. Bar graph shows quantification of GANP protein 
levels relative to GAPDH for A-C. Bar graph quantification of GANP staining in the nucleus and 
the nuclear envelope as fraction of cells from blindly counted cells for that sample. Cells were 
classified into GANP + (black), intermediate (-/+) (dark grey) and GANP - (light grey) cells based 
on staining in the nuclear envelope and interior. Quantification is based on technical triplicate 
samples of the same experiment n
average
=112 for samples A and technical duplicates n
average
= 136 for 
samples B, n
average
=90 for duplicate samples in experiment C. Dapi stains nuclei. Scale bars 10 µm. 
See Supplementary material figure S1A for control samples for experiments B and C. 
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Figure 3. Ultrastructural assessment of the nuclear pore with electron microscopy. 
Electron micrographs of patient FIN1/2, AUS and control fibroblasts. Blue arrows indicate nuclear 
pore complexes and black arrows the nuclear envelope. Scale bars 2 µm. 
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Figure 4. Differentially expressed genes in patient fibroblasts. 
A. Pearson hierarchical correlation of gene expression of affected individuals’ and control 
fibroblasts. C indicates control. B. Volcano plot showing expression differences and significance 
for genes. Of the TREX-2/SAGA complex associated genes MCM3AP and ATXN7L3B are 
indicated in green, and non-significant USP22, ENY2 and ATXN7L3 in grey. C. Heatmap of 
expression differences (to gene average) for the enriched genes in REACTOME category "neuronal 
system" See full list in Supplementary material Table S2. D. Gene-set enrichment analysis. See full 
list in supplementary material Table S3. 
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Figure 5. Downregulation of intronless genes in patient fibroblasts.  
A. Distribution of exons across differentially expressed genes. B. Volcano plot indicating 
expression differences for up- and downregulated intronless genes in log2FC in patient vs. control 
samples and significance as –log10 p-value. C. qPCR validations of intronless genes ATXN7L3B, 
EID1 and TSPYL4 relative to GAPDH. Each dot represents average of three technical replicates of 
an affected (n=8) or control individual (n=4). ** p<0.0001. Error bars show mean with SD.  
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Figure 6. ATXN7L3B RNA in situ hybridization shows reduced signal in patient fibroblasts. 
A. Patient and control fibroblasts hybridized with ATXN7L3B target probe (Cy3) and dapi (blue). 
White square indicates focus area on the other image. Scale bars 10 µm. B. Average of punctae 
number in cells/line is plotted in the bar graph. p<0.05. Mean with SD plotted. 
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